EcoDrugPlus

Mapk Activated Protein Kinase 2

Ensembl ID : ENSEEUG00000000525
Gene Symbol: MAPKAPK2
1 External references
240 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSEEUG00000013849
Gene Symbol: MDM2
1 External references
257 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSEEUG00000005655
Gene Symbol: MET
1 External references
207 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSEEUG00000002122
Gene Symbol: NQO1
1 External references
195 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSEEUG00000011243
Gene Symbol: NFE2L2
1 External references
216 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSEEUG00000001999
Gene Symbol: NPC1L1
1 External references
190 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSEEUG00000002774
Gene Symbol: ROS1
1 External references
125 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEUG00000011360
Gene Symbol: RAF1
1 External references
223 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSEEUG00000008504
Gene Symbol: ROCK1
1 External references
211 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSEEUG00000002237
Gene Symbol: SEM1
1 External references
156 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSEEUG00000005742
Gene Symbol: SRC
1 External references
261 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSEEUG00000005759
Gene Symbol: TEK
1 External references
166 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).